When most people think about pharmaceutical companies, they’re liking picturing huge corporations that are frequently in the news. For many, huge pharmaceutical companies have become a household name, and they might not even be aware that many pharmaceutical companies are actually small to midsize. Even within the pharmaceutical industry, smaller businesses don’t get the support […]
Tedor Pharma works every day to produce top-quality pharmaceutical products for our clients. The aspect of our business that separates us from others in the industry is that we see the process through from the early stages to commercialization, rather than focusing on only one aspect of the process and then passing it off to […]
In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. Within the industry itself, of course, we understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. For reference, they mean, respectively, “finished […]
There are many drugs on the market, with new ones being created all the time. With so many pharmaceuticals out there, getting one on the market might seem easier than it actually is. However, developing new medicines is a massive undertaking. This rigorous process is to ensure that pharmaceuticals are effective and safe enough to […]
Cumberland, Rhode Island | June 02, 2020 | TEDOR Pharma is pleased to announce they have agreed to work with Cardinal Health Regulatory Sciences to deliver integrated solutions to the biopharmaceutical industry. These solutions would leverage the regulatory consulting expertise of Cardinal Health and TEDOR’s world class oral solid dose manufacturing capabilities and exclusive North […]
When you get prescribed medication, or when you buy anything over-the-counter, you expect it to make you feel better. On any drug, you can find a list of risks and side effects, but unless you have a specific reason to be concerned, it likely isn’t something you put much thought into. Many of us can […]
Being able to split a pill into smaller doses easily is something many people are looking for in pharmaceuticals. At some point, many of us have done this. While breaking a pill in half is a common practice, it can cause more problems than people may realize. Even some pills that are specifically meant to […]
At Tedor Pharma, we enjoy letting potential clients know that we are a full-service pharmaceutical development company. By that, we mean that we are capable of seeing your projects through from formulation to finished product to commercialization. That’s what differentiates us from other CDMOs, or contract development and manufacturing organizations. Instead of focusing all our […]
CUMBERLAND, RI – May 05, 2020 – TEDOR Pharma Inc., www.tedorpharma.com a full-service contract development and manufacturing organization (CDMO), today announced that they entered into an agreement to provide cGMP contract manufacturing services for the Center for International Health Research at Rhode Island Hospital. TEDOR will support a clinical trial that will inform the safety […]
In an exclusive interview with Drug Development and Delivery, Doug Drysdale, President & CEO of TEDOR Pharma, Inc explains how TEDOR is addressing the needs of small- and medium-size companies by developing innovative and repurposed small molecules for unmet medical needs. TEDOR is the exclusive North American provider of FLEXITAB In the interview, Drysdale provides […]
Dear Valued Customer, In light of the new coronavirus (COVID-19), we would like to provide an update on the actions TEDOR is taking to protect our employees, our operations and our ability to serve you, our valued customers. TEDOR’s top priority as a company is the health and wellness of our employees and their families, […]
Terence Novak, chief operating officer, TEDOR Pharma shares insights into the market trends, obstacles, and future growth of CDMOs in an online feature at Contract Pharma. Novak targets infrastructure and manufacturing capacity challenges as being critical capabilities that need to be addressed to provide quality contract development and manufacturing organization (CDMO) services. To read more, […]
CUMBERLAND, RI – February 19, 2020 – We are pleased to announce that TEDOR Pharma has been chosen as a winner for Providence Business News (PBN) 7th Annual Manufacturing Awards Program for Family-Owned Manufacturer. Companies competing for the award were judged based on confidential surveys and management reports with top honorees being named in a […]
CUMBERLAND, RI – January 20, 2020 – TEDOR Pharma, a Contract Development and Manufacturing Organization with a 19-year operating history, is pleased to announce Frank Sorce is joining TEDOR as the new Regional Business Development Director. Sorce will be reporting to Chief Operating Officer, Terry Novak. Frank Sorce brings with him 30 years of experience […]
Cumberland, RI – October 8, 2019 – Tedor Pharma, Inc., a full-service contract development and manufacturing organization (CDMO), today announced that they entered into an agreement to provide cGMP contract manufacturing services for Sequential Medicine Ltd.’s triple combination drug product for the short-term treatment of transient insomnia. Sequential Medicine’s product has demonstrated impressive efficacy in early […]
David Vario, TEDOR Pharma’s Vice President of Quality & Regulatory, will be speaking at the CMO Quality Oversight & Risk Management Summit in Boston, MA. This two day event will be held on September 23rd and September 24th. David will be partnering with Gerd Kochendoerfer, Senior Vice President, Head of Operations at Pellepharm to speak on contract negotiation […]
TEDOR Pharma is happy to announce the schedule of trade shows and conferences we will be attending in September 2019: September 23-24, 2019 American Pharma Outsourcing Summit 2019 @The Philadelphia 201 Hotel, Philadelphia, PA Connect with TEDOR Pharma to exchange strategic insights and best practices in manufacturing when selecting a CDMO to maximize efficiency while […]
TEDOR Pharma is pleased to announce the addition of Dr. Heather Lane to our executive team as Director of Business Operations. Dr. Lane has over 20 years of demonstrated experience in business, sales, and marketing in the pharmaceutical and healthcare industries. She holds both a DC (Doctor of Chiropractic) title and a BS in Human […]
TEDOR expects to gain operational efficiencies for future growth using AssurX platform. Morgan Hill, CA., June 19, 2019 – AssurX, Inc. , a leader in enterprise quality management software today announced that oral solid dose contract development and manufacturing organization (“CDMO”) TEDOR Pharma Inc. has selected the AssurX platform to fully automate their quality and compliance [...]
Adial Reaffirms on Track to Commence Phase 3 Trial in Q3 2019 Charlottesville, VA – June 6, 2019 – Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, and Tedor Pharma, Inc., a full-service contract development and manufacturing organization (CDMO), today announced that they entered [...]
Patent protected FLEXITAB technology delivers flexible and precise dosing from a single extended release tablet CUMBERLAND, RI – June 4, 2019 – TEDOR Pharma Inc., a Contract Development and Manufacturing Organization with an 18-year operating history, is pleased to announce its partnership with Altus Formulation as the exclusive North American licensee and provider of FLEXITAB [...]
Tedor is pleased to announce the addition of David Vario as vice president of quality and regulatory affairs. David has over 25 years of experience in the pharmaceutical, biotech and medical device industry. He holds an BS in Mechanical Engineering from Northeastern University and is a certified Six Sigma Green Belt. He is well-versed in […]
TEDOR Pharma announced today the closing of a recapitalization and reorganization of its business, funded by investments from DORA Ventures, Inc.
Tedor Pharma is proud to introduce a bold, new brand identity.
A Significant Investment Towards Advancing Tedor Pharma’s Large Scale Commercial Capabilities.
Successful Leader brings Senior Level Operations, Industry Experience. Tedor Pharma, Inc. is announcing the appointment of Roger D. Martin as Chief Operating Officer.
Talented Leader brings Senior Level Operations, Pharmaceutical Sales Experience. Tedor Pharma, Inc. is announcing the appointment of Carl E. Wooten as President and Chief Executive Officer effective February 22, 2016.